Skip to content

SCHEDULE 13GAccepted Mar 4, 3:16 PM ET

Cullinan Therapeutics, Inc. SCHEDULE 13G

Kynam Capital Management, LP

Accepted (ET)

3:16 PM

Mar 4, 2026

Filed

Mar 4, 2026

Documents

1

Size

9.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.